Literature DB >> 32055488

Surgical strategies for postchemotherapy testis cancer.

Saum Ghodoussipour1, Siamak Daneshmand1.   

Abstract

The surgical management of disseminated disease has long been an essential component in the management of patients with testis cancer. While the indications for surgery have been narrowed since the advent of cisplatin based chemotherapy, resection remains essential to provide long-term survival. The indications for surgery vary by histology and rely on adequate preoperative imaging to evaluate for residual disease. Surgery for postchemotherapy testis cancer is challenging and requires that surgeons be prepared for extraretroperitoneal resections and adjunctive procedures as necessary. Herein, we review the imaging options that are essential for surgical planning and the various surgical techniques that are often necessary in this challenging situation. 2020 Translational Andrology and Urology. All rights reserved.

Entities:  

Keywords:  Testis cancer; germ cell tumor; retroperitoneal lymph node dissection

Year:  2020        PMID: 32055488      PMCID: PMC6995844          DOI: 10.21037/tau.2019.09.43

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  45 in total

1.  Management of post-chemotherapy residual masses in advanced seminoma.

Authors:  Aude Flechon; Emmanuelle Bompas; Pierre Biron; Jean-Pierre Droz
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

2.  Complications of retroperitoneal lymphadenectomy.

Authors:  A L Sago; T P Ball; D E Novicki
Journal:  Urology       Date:  1979-03       Impact factor: 2.649

3.  FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.

Authors:  Alexander Becherer; Maria De Santis; Georgios Karanikas; Monica Szabó; Carsten Bokemeyer; Bernhard M Dohmen; Jörg Pont; Robert Dudczak; Christian Dittrich; Kurt Kletter
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

4.  Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.

Authors:  Shaheen R Alanee; Brett S Carver; Darren R Feldman; Robert J Motzer; George J Bosl; Joel Sheinfeld
Journal:  Urology       Date:  2016-05-25       Impact factor: 2.649

5.  Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Authors:  Scott C Johnson; Zachary L Smith; Charles Nottingham; Zeyad R Schwen; Stephen Thomas; Elliot K Fishman; Nam Ju Lee; Philip M Pierorazio; Scott E Eggener
Journal:  Urology       Date:  2018-09-01       Impact factor: 2.649

6.  2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

Authors:  M Bachner; Y Loriot; M Gross-Goupil; P A Zucali; A Horwich; J-R Germa-Lluch; C Kollmannsberger; F Stoiber; A Fléchon; K Oechsle; S Gillessen; J Oldenburg; G Cohn-Cedermark; G Daugaard; F Morelli; A Sella; S Harland; M Kerst; J Gampe; C Dittrich; K Fizazi; M De Santis
Journal:  Ann Oncol       Date:  2011-04-02       Impact factor: 32.976

Review 7.  Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor.

Authors:  Saum Ghodoussipour; Siamak Daneshmand
Journal:  Urol Clin North Am       Date:  2019-05-21       Impact factor: 2.241

8.  The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.

Authors:  J R Spermon; L F De Geus-Oei; L A L M Kiemeney; J A Witjes; W J G Oyen
Journal:  BJU Int       Date:  2002-04       Impact factor: 5.588

9.  The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.

Authors:  Anna C Pfannenberg; Karin Oechsle; Carsten Bokemeyer; Christian Kollmannsberger; Bernhard M Dohmen; Roland Bares; Jörg T Hartmann; Reinhard Vonthein; Claus D Claussen
Journal:  World J Urol       Date:  2004-01-21       Impact factor: 4.226

10.  2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

Authors:  Maria De Santis; Alexander Becherer; Carsten Bokemeyer; Franz Stoiber; Karin Oechsle; Franz Sellner; Alois Lang; Kurt Kletter; Bernhard M Dohmen; Christian Dittrich; Jörg Pont
Journal:  J Clin Oncol       Date:  2004-03-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.